Daylight saving time (DST) shifts the clock by one hour, yet the pineal gland does not reset on command. Melatonin secretion follows a genetically encoded rhythm that can lag for days or weeks after the time change. Epitalon (a synthetic tetrapeptide, Ala-Glu-Asp-Gly) has been studied in the context of pineal function and circadian regulation. This article examines published research on Epitalon, GHK-Cu, and related bioregulator peptides (Vesugen, Cortagen, Pinealon, Thymalin) in the context of circadian disruption. Specific outcomes referenced from studies represent observed effects in defined populations under defined conditions. The focus is on mechanisms, not personal protocols.
The suprachiasmatic nucleus (SCN) is the master circadian pacemaker. It receives light input and coordinates peripheral clocks, including the pineal gland. After a DST shift, the SCN adjusts faster than downstream tissues. The pineal melatonin rhythm can remain misaligned for several days. In older adults, this realignment is slower. A 2017 study in Current Biology found that melatonin onset shifted by about 30 minutes per day after a 6-hour phase advance, but only 15 minutes per day after a phase delay. A one-hour DST shift is smaller, yet even this can produce measurable sleep fragmentation and daytime sleepiness for up to a week in sensitive individuals.
Epitalon was originally isolated from bovine pineal extract by Vladimir Khavinson in the 1980s. In animal models, Epitalon increased nighttime melatonin production and restored the circadian rhythm of melatonin in aged rats. A 2003 paper in Neuroendocrinology Letters reported that Epitalon administration over 6 days increased pineal melatonin secretion in old rhesus monkeys to levels seen in young animals. The mechanism appears to involve upregulation of arylalkylamine N-acetyltransferase (AANAT), the rate-limiting enzyme for melatonin synthesis. Epitalon does not act as a direct melatonin replacement. Instead, it appears to support the pineal gland's own synthetic capacity.
GHK-Cu (glycyl-L-histidyl-L-lysine copper) is a copper-binding tripeptide. It is best known for effects on collagen synthesis and wound healing. Less discussed is its role in gene expression related to circadian rhythms. A 2018 study in Scientific Reports showed that GHK-Cu modulated the expression of several clock genes in human fibroblasts, including CLOCK and BMAL1. The effect was modest but reproducible. In the context of DST disruption, GHK-Cu may influence the peripheral clocks in skin and vascular tissue, which are among the slowest to resynchronize after a phase shift.
GHK-Cu also interacts with copper-dependent enzymes. Dopamine beta-hydroxylase, which converts dopamine to norepinephrine, requires copper. Norepinephrine is the primary neurotransmitter driving pineal melatonin synthesis at night. A 2015 review in Biomolecules noted that copper availability can influence circadian amplitude in peripheral tissues. This does not mean GHK-Cu directly increases melatonin. It suggests a permissive role: adequate copper status supports the enzymatic machinery that the pineal gland uses to produce melatonin. GHK-Cu and Epitalon have been studied together for skin collagen density and fibroblast senescence, and that same fibroblast population expresses clock genes.
Vesugen is a short peptide (Lys-Glu-Asp) studied for vascular endothelial function. Cortagen (Ala-Glu-Asp-Pro) targets neural tissue. Pinealon (Glu-Asp-Arg) is a tripeptide with reported neuroprotective effects. None of these are direct chronobiotics. However, circadian disruption after DST involves more than the pineal gland. Vascular endothelial cells have their own circadian clocks. A 2019 paper in Cell showed that endothelial BMAL1 deletion caused blood pressure dysregulation and altered vascular tone. Vesugen has been investigated in models of endothelial aging. GHK-Cu and Vesugen have been examined for vascular rejuvenation via endothelial aging, which is relevant because endothelial clock gene expression declines with age.
Cortagen and Pinealon have been studied in models of cognitive decline and neural repair. The SCN itself is a neural structure. Pinealon increased neuronal survival in culture after oxidative stress, according to a 2007 study in Bulletin of Experimental Biology and Medicine. Cortagen improved learning and memory in aged rats. Neither peptide has been shown to directly shift the SCN clock. But if DST disruption worsens cognitive performance through sleep loss, peptides that support neural resilience may reduce the functional impact. Epitalon, Pinealon, and Cortagen have been discussed as a circadian reset stack, though the evidence is largely preclinical.
Thymalin is a peptide complex derived from the thymus. It has been studied for immune restoration in aging. The immune system has its own circadian rhythm. Circulating lymphocyte counts peak at night. Cytokine production follows a daily pattern. A 2020 study in Nature Reviews Immunology described how circadian disruption, including DST shifts, can alter immune surveillance and increase susceptibility to infection. Thymalin has been shown to normalize T-cell subsets in aged animals. Whether it can accelerate immune clock realignment after a phase shift is unknown.
Epitalon and Thymalin have been combined in some Russian studies for telomere protection and immune aging. The Epitalon and Thymalin stack has been reviewed for telomere protection versus immune aging. In the context of DST, the immune clock may lag behind the SCN by several days. A peptide that supports thymic output could theoretically reduce the window of immune vulnerability. But no published human trial has tested this specific question. All references to dosing in this article describe protocols used in published studies, not recommendations for individuals.
Human trials of Epitalon are limited. The most cited is a 2003 study by Khavinson and colleagues in Bulletin of Experimental Biology and Medicine. They administered Epitalon to 70 elderly subjects for 3 years, in two 10-day courses per year. The study reported a reduction in all-cause mortality (from 17% to 8%) and a stabilization of melatonin secretion. However, the study had no placebo control and was not randomized. A 2006 follow-up reported similar findings but with the same methodological weaknesses. These are observational signals, not definitive evidence.
For GHK-Cu, human data on circadian rhythms are even thinner. Most studies focus on wound healing, skin elasticity, and hair growth. The clock gene modulation seen in fibroblasts has not been replicated in human pineal tissue. For Vesugen, Cortagen, and Pinealon, human circadian data are essentially absent. The published literature consists of animal models, cell culture, and small uncontrolled trials. This is an editorial discussion of published research. It is not a treatment plan.
The circadian system is robust but not infinitely flexible. A one-hour DST shift is a mild stressor for most people. For older adults, shift workers, and those with pre-existing sleep disorders, the misalignment can persist. Peptides like Epitalon may theoretically support pineal melatonin synthesis. GHK-Cu may support peripheral clock gene expression. Vesugen, Cortagen, Pinealon, and Thymalin may support the vascular, neural, and immune components of the circadian network. But the direct evidence that any of these compounds accelerates realignment after DST is lacking.